Latest News Releases From The Newsroom
Pfizer to End License Deal with Theravance Bio; Truist Bullish On Vail Resorts and Leonardo DRS
June 09th, 2023
Theravance Biopharma Ireland Limited, an affiliate of Theravance Biopharma, Inc. (Nasdaq: TBPH), entered into a global license agreement with Pfizer Inc. (NYSE: PFE) in December 2019 for its preclinical skin-selective, locally acting pan-JAK inhibito. Read more
Aehr Test Systems Gets $13.7M in Orders; Fisker Targets Chinese Market
June 09th, 2023
Aehr Test Systems (Nasdaq: AEHR) has secured significant orders worth $13.7 million from a leading Fortune 500 semiconductor device supplier, who is a major player in the automotive semiconductor market. The orders are for Aehr's WaferPak fu. Read more
Vertex Pharma, CRISPR Surge On Exa-cel Trials Data; Sonoma Pharma Soars on Pulse Lavage Irrigation Solution
June 09th, 2023
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics AG (Nasdaq: CRSP) have announced positive results from pivotal trials for their investigational treatment, exagamglogene autotemcel (exa-cel), in patients with transfusion-dep. Read more
Canaccord Bullish on Joby Aviation, Lilium, Vertical Aerospace, Eve, Archer Aviation: eVTOL Stocks
June 09th, 2023
Joby Aviation, Inc. (NYSE: JOBY), a leading electric aviation company focused on the development of vertical takeoff and landing (VTOL) aircraft, has been initiated with a Buy rating and Price Target of $8 by Canaccord Genuity. With $JOBY cl. Read more
Braze, Duckhorn, General Motors, and Tesla: Earnings, Guidance, and Collaboration Updates
June 09th, 2023
Braze, Inc. (Nasdaq: BRZE) reported a first-quarter fiscal 2024 loss of $0.13 per share, better than the consensus estimate of a loss of $0.18 per share. The company has also provided guidance for the second quarter, expecting an adjusted lo. Read more
A Snapshot of Potential Upsides: Oculis, Zscaler, MercadoLibre, FIGS, Home Depot, AMETEK
June 09th, 2023
Oculis Holding AG (Nasdaq: OCS), a leading pharmaceutical company specializing in developing innovative therapies for ocular diseases, has been initiated with an Outperform rating and a price target of $58 by Robert W. Baird. With $OCS closing at . Read more
Raytheon Secures $372.14M Contract; FDA OKs Sientra's MRI-Compatible Tissue Expander AlloX2 Pro
June 08th, 2023
Raytheon Intelligence & Space, a key business segment of Raytheon Technologies Corp. (NYSE: RTX), has been awarded a significant contract worth $372,137,000 by the Naval Air Warfare Center Weapons Division. The contract entails updates, impr. Read more
DocuSign Q1 Beats, ContraFect Conference Buzz, Bullish Sentiment Towards Uber and Lufax
June 08th, 2023
DocuSign, Inc. (Nasdaq: DOCU), a renowned provider of electronic signature technology and digital transaction management services, reported its first-quarter fiscal 2024 financial results. The company exceeded expectations with adjusted earnings per . Read more
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
June 08th, 2023
Agency issues order to additional GPO as it examines the impact of vertically integrated PBMs on prescription drug prices and access Washington D.C. / CRWE PRESS RELEASE / June 8, 2023 - As part of its ongoing study on pharmacy be. Read more
President Joe Biden Responds to Wildfires in Canada: A Call for Action on Climate Change
June 08th, 2023
The devastating wildfires in Canada have once again brought attention to the urgent issue of climate change, with millions of Americans experiencing the effects of the resulting smoke. President Joe Biden has issued a statement emphasizing the need f. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login